| NDC Code | 25021-263-10 |
|---|
| Package Description | 1 VIAL in 1 CARTON (25021-263-10) / 10 mL in 1 VIAL |
|---|
| Product NDC | 25021-263 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Doxorubicin Hydrochloride Liposome |
|---|
| Non-Proprietary Name | Doxorubicin Hydrochloride |
|---|
| Dosage Form | INJECTION, SUSPENSION, LIPOSOMAL |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20260301 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA219881 |
|---|
| Manufacturer | Sagent Pharmaceuticals |
|---|
| Substance Name | DOXORUBICIN HYDROCHLORIDE |
|---|
| Strength | 2 |
|---|
| Strength Unit | mg/mL |
|---|
| Pharmacy Classes | Anthracycline Topoisomerase Inhibitor [EPC], Anthracyclines [CS], Topoisomerase Inhibitors [MoA] |
|---|